Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals (VRTX) Stock Price & Analysis


VRTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$276.57 - $367.00
Previous Close$349.53
Average Volume (3M)1.01M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$11.24B
Total Debt (Recent Filing)$767.60M
Price to Earnings (P/E)27.0
Nov 01, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)12.94
Shares Outstanding258,094,815
10 Day Avg. Volume895,741
30 Day Avg. Volume1,012,297
Standard Deviation0.08
Financial Highlights & Ratios
Price to Book (P/B)6.55
Price to Sales (P/S)36.18
Price to Cash Flow (P/CF)19.90
P/FCF Ratio20.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside9.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vertex Pharmaceuticals’s price range in the past 12 months?
Vertex Pharmaceuticals lowest stock price was $276.57 and its highest was $367.00 in the past 12 months.
    What is Vertex Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Vertex Pharmaceuticals’s upcoming earnings report date?
    Vertex Pharmaceuticals’s upcoming earnings report date is Nov 01, 2023 which is in 36 days.
      How were Vertex Pharmaceuticals’s earnings last quarter?
      Vertex Pharmaceuticals released its earnings results on Aug 01, 2023. The company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.859 by $0.031.
        Is Vertex Pharmaceuticals overvalued?
        According to Wall Street analysts Vertex Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vertex Pharmaceuticals pay dividends?
          Vertex Pharmaceuticals does not currently pay dividends.
          What is Vertex Pharmaceuticals’s EPS estimate?
          Vertex Pharmaceuticals’s EPS estimate is $3.93.
            How many shares outstanding does Vertex Pharmaceuticals have?
            Vertex Pharmaceuticals has 258,094,820 shares outstanding.
              What happened to Vertex Pharmaceuticals’s price movement after its last earnings report?
              Vertex Pharmaceuticals reported an EPS of $3.89 in its last earnings report, beating expectations of $3.859. Following the earnings report the stock price went up 3.066%.
                Which hedge fund is a major shareholder of Vertex Pharmaceuticals?
                Among the largest hedge funds holding Vertex Pharmaceuticals’s share is Bridgewater Associates, LP. It holds Vertex Pharmaceuticals’s shares valued at 62M.


                  Vertex Pharmaceuticals Stock Smart Score

                  The Vertex Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Vertex Pharmaceuticals

                  Based in Massachusetts and incorporated in 1989, Vertex Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.


                  Top 5 ETFs holding VRTX

                  Market Value
                  Smart Score
                  Global X S&P 500 Covered Call ETF
                  iShares ESG Screened S&P 500 ETF
                  Global X S&P 500 Covered Call & Growth ETF
                  Global X S&P 500 ESG Covered Call ETF
                  Global X S&P 500 Tail Risk ETF
                  Up to five ETFs with an Outperform Smart Score that hold VRTX. The ETFs are listed according to market value of VRTX within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Alnylam Pharma
                  Gilead Sciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis